These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 890698)

  • 1. Melphalan in advanced prostatic cancer: a pilot study.
    Houghton AL; Robinson MR; Smith PH
    Cancer Treat Rep; 1977 Aug; 61(5):923-4. PubMed ID: 890698
    [No Abstract]   [Full Text] [Related]  

  • 2. Melphalan in metastatic cancer of the prostate: a pilot study.
    Franks CR
    Cancer Treat Rep; 1979 Feb; 63(2):228-9. PubMed ID: 445500
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro cytotoxic effect of melphalan and pilot phase II study in hormone-refractory prostate cancer.
    Mougenot P; Bressolle F; Culine S; Solassol I; Poujol S; Pinguet F
    Anticancer Res; 2006; 26(3B):2197-203. PubMed ID: 16821586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer.
    Sarfaty GA; Alder SJ; McLean RG
    Med J Aust; 1984 Feb; 140(4):219-21. PubMed ID: 6694625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience.
    Matzkin H; Greenstein A; Kaver I; Braf Z
    Isr J Med Sci; 1989 Jul; 25(7):388-92. PubMed ID: 2474522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot study.
    Ashenhurst J; Bitran JD; Robin E; Desser RK; Shapiro C; Kozloff MF; Billings AA
    Cancer Treat Rep; 1981; 65(9-10):869-72. PubMed ID: 7273020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of advanced prostatic carcinoma using estramustinphosphate].
    Ferrer Roda J
    Actas Urol Esp; 1983; 7(1):29-34. PubMed ID: 6192690
    [No Abstract]   [Full Text] [Related]  

  • 9. [The antiblastic effects of a compound recently used in the therapy of tumors: Ortho-Merphalan (Merophan). Studies in patients with gastric carcinoma in advanced stages].
    Gardini GF; Maltoni C; Castellari S; Peretti S
    Bull Sci Med (Bologna); 1968; 140(1):82-3. PubMed ID: 4907828
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of advanced prostatic carcinoma with total androgenic blockade using bilateral orchidectomy and flutamide: experience at the National Cancer Institute in Mexico.
    Mendoza-Valdés A; Ocampo-del-Carpio O; De-la-Garza J
    Semin Oncol; 1991 Oct; 18(5 Suppl 6):19-20. PubMed ID: 1948118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clodronate in the palliative therapy of bone-metastasized prostatic carcinoma].
    Vorreuther R; Klotz T; Engelking R
    Urologe A; 1992 Mar; 31(2):63-6. PubMed ID: 1373255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.
    de Palo GM; de Lena M; Di Re F; Luciani L; Valagussa P; Bonadonna G
    Surg Gynecol Obstet; 1975 Dec; 141(6):899-902. PubMed ID: 1103333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostatic carcinoma].
    Sökeland J
    Med Klin; 1970 Jun; 65(23):1113-4. PubMed ID: 5521268
    [No Abstract]   [Full Text] [Related]  

  • 14. Melphalan in metastatic cancer of the prostate.
    Franks CR
    Cancer Treat Rev; 1979 Jun; 6 Suppl():121-5. PubMed ID: 498165
    [No Abstract]   [Full Text] [Related]  

  • 15. Flutamide monotherapy as primary treatment in advanced prostatic carcinoma.
    Delaere KP; Van Thillo EL
    Semin Oncol; 1991 Oct; 18(5 Suppl 6):13-8. PubMed ID: 1948117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences in the treatment of advanced prostatic cancer using Turisteron with special reference to cardiovascular complications].
    Drawz B; Hoffmann L; Drawz G; Russbüldt R
    Z Urol Nephrol; 1987 Mar; 80(3):171-5. PubMed ID: 3604473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy with hexamethylamine (Hexalen, Altretamine, Hexastat) and sarcolysine in advanced ovarian carcinoma].
    Gershanovich ML; Livshits ME; Antipenkova VI
    Vopr Onkol; 2000; 46(5):604-7. PubMed ID: 11202196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.
    Gershenson DM; Morris M; Burke TW; Levenback C; Wolf J; Lee JJ; Thall PF; Atkinson EN; Silva EG; Wharton JT
    Cancer; 1999 Dec; 86(11):2291-300. PubMed ID: 10590370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of advanced prostatic carcinoma with medroxyprogesterone.
    Rafla S; Johnson R
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):261-7. PubMed ID: 4208339
    [No Abstract]   [Full Text] [Related]  

  • 20. European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer.
    Jones WG; Fosså SD; Bono AV; Klijn JG; De Pauw M; Sylvester R
    Cancer Treat Rep; 1987 Dec; 71(12):1317-8. PubMed ID: 3480046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.